SEC 13F Intelligence

Burrage Capital Management LLC / XENE

Burrage Capital Management LLC’s Xenon Pharmaceuticals Inc Position

Does Burrage Capital Management LLC own Xenon Pharmaceuticals Inc (XENE)? Not currently — the last reported position was 200.0K shares worth $2M in Q1 2020; the fund’s latest 13F (Q3 2021) no longer reports it.

Position Value
$2M
Q1 2020
Shares
200.0K
% of Portfolio
+2.08%
Quarters Held
1
position exited

Position History XENE

Reported value by quarter
Q1 ’20: $2MQ1 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2020200.0K$2M+2.08%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Burrage Capital Management LLC’s full portfolio or all institutional holders of XENE.